Bell Abell Bio Co.
Latest round
- Seed
Last raised
- Apr 2023
Total raised
- Undisclosed
Investors
- 1
About Bell Abell Bio Co.
, Ltd. operates as a manufacturer of natural biomaterials and provides industrialization solutions. As of 2023, Byung-Chan Chung serves as the CEO of the company. The company develops functional biomaterials and offers industrialization solutions based on functional substance efficacy verification using its own efficacy screening system of domestic natural raw materials. The firm also provides smart farm cultivation services.
Who invested in Bell Abell Bio Co.
1 investor across 1 round
See all investors in Bell Abell Bio Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 28, 2023
Amount
Undisclosed
Investors
Questions about Bell Abell Bio Co.
Who invested in Bell Abell Bio Co.?
Bell Abell Bio Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bell Abell Bio Co. raised?
Bell Abell Bio Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bell Abell Bio Co. last raise money?
Bell Abell Bio Co.'s most recent round on record is a Seed, in Apr 2023.
What does Bell Abell Bio Co. do?
Bell Abell Bio Co. is a materials company.
Where is Bell Abell Bio Co. headquartered?
Bell Abell Bio Co. is headquartered in Gimhae, South Korea.
Which VCs invest in companies like Bell Abell Bio Co.?
Among active investors with capital left to deploy, Legend Capital, Shanghai STVC Group, GL Ventures and Fortune Capital back materials companies at Bell Abell Bio Co.'s stage. Their profiles are linked below.
VCs backing materials startups at Seed
Raising like Bell Abell Bio Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.